COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 190 filers reported holding COHERUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,831,639 | -42.5% | 489,743 | -34.4% | 0.00% | 0.0% |
| Q2 2023 | $3,186,125 | -65.9% | 746,165 | -45.4% | 0.00% | -66.7% |
| Q1 2023 | $9,355,886 | -35.3% | 1,367,820 | -25.1% | 0.00% | -40.0% |
| Q4 2022 | $14,467,000 | -17.6% | 1,826,696 | +0.0% | 0.01% | -16.7% |
| Q3 2022 | $17,547,000 | +24.7% | 1,826,111 | -6.1% | 0.01% | +20.0% |
| Q2 2022 | $14,074,000 | -41.3% | 1,944,003 | +4.7% | 0.01% | -28.6% |
| Q1 2022 | $23,979,000 | -11.0% | 1,857,132 | +10.0% | 0.01% | 0.0% |
| Q4 2021 | $26,939,000 | +20.5% | 1,687,825 | +21.4% | 0.01% | 0.0% |
| Q3 2021 | $22,351,000 | +16.2% | 1,390,844 | +0.0% | 0.01% | +16.7% |
| Q2 2021 | $19,234,000 | +5.3% | 1,390,714 | +11.3% | 0.01% | 0.0% |
| Q1 2021 | $18,260,000 | -45.1% | 1,250,009 | -34.6% | 0.01% | -50.0% |
| Q4 2020 | $33,231,000 | -23.4% | 1,912,007 | -19.2% | 0.01% | -33.3% |
| Q3 2020 | $43,387,000 | -36.6% | 2,365,728 | -38.2% | 0.02% | -37.9% |
| Q2 2020 | $68,407,000 | +22.7% | 3,830,113 | +11.4% | 0.03% | 0.0% |
| Q1 2020 | $55,768,000 | +98.8% | 3,438,334 | +120.7% | 0.03% | +141.7% |
| Q4 2019 | $28,056,000 | +101.7% | 1,558,138 | +126.9% | 0.01% | +100.0% |
| Q3 2019 | $13,913,000 | +234.0% | 686,792 | +264.3% | 0.01% | +200.0% |
| Q2 2019 | $4,165,000 | -44.4% | 188,510 | -65.7% | 0.00% | -33.3% |
| Q1 2019 | $7,493,000 | +59.8% | 549,323 | +6.0% | 0.00% | +50.0% |
| Q4 2018 | $4,690,000 | +53.7% | 518,118 | +180.0% | 0.00% | +100.0% |
| Q3 2018 | $3,051,000 | -1.6% | 185,010 | -16.4% | 0.00% | 0.0% |
| Q2 2018 | $3,100,000 | -32.0% | 221,350 | -46.3% | 0.00% | -50.0% |
| Q1 2018 | $4,558,000 | +2.5% | 412,455 | -18.4% | 0.00% | 0.0% |
| Q4 2017 | $4,448,000 | +2.6% | 505,575 | +55.7% | 0.00% | 0.0% |
| Q3 2017 | $4,335,000 | -19.2% | 324,690 | -13.1% | 0.00% | -33.3% |
| Q2 2017 | $5,362,000 | -23.5% | 373,725 | +12.7% | 0.00% | -25.0% |
| Q1 2017 | $7,011,000 | -2.9% | 331,492 | +29.3% | 0.00% | 0.0% |
| Q4 2016 | $7,218,000 | +486.8% | 256,371 | +537.3% | 0.00% | +300.0% |
| Q1 2015 | $1,230,000 | – | 40,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |